Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar

Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar

<h3>Background</h3><p dir="ltr">Some studies have reported that influenza vaccination is associated with lower risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and/or coronavirus disease 2019 (COVID-19) morbidity and mortality. This study aim...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Elias Tayar (16488567) (author)
مؤلفون آخرون:	Sami Abdeen (14779537) (author), Muna Abed Alah (14779534) (author), Hiam Chemaitelly (439114) (author), Iheb Bougmiza (8962583) (author), Houssein H. Ayoub (9262512) (author), Anvar Hassan Kaleeckal (11847034) (author), Ali Nizar Latif (11570540) (author), Riyazuddin Mohammad Shaik (11847037) (author), Hamad Eid Al-Romaihi (6837251) (author), Mohamed H. Al-Thani (11847049) (author), Roberto Bertollini (9538620) (author), Laith J. Abu-Raddad (9262524) (author), Abdullatif Al-Khal (11721410) (author)
منشور في:	2023
الموضوعات:	Biomedical and clinical sciences Cardiovascular medicine and haematology Clinical sciences Health sciences Public health Influenza COVID-19 Vaccine Case-control Immunity Epidemiology
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة

Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar
حسب: Elias, Tayar
منشور في: (2023)

Seasonal influenza disease and annual influenza vaccine coverage at Primary Health Care Corporation, Qatar, 2018–2019: a descriptive study
حسب: Seema Sylvia Dsouza (21347870)
منشور في: (2022)

Editorial of Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine
حسب: Salman M. Toor (8854751)
منشور في: (2020)

Knowledge, attitudes, perceptions, and practice toward seasonal influenza and its vaccine: A cross-sectional study from a country of conflict
حسب: Wesam S. Ahmed (10170053)
منشور في: (2023)

Attitudes, motivators, and barriers toward influenza vaccination for children: a study from a conflict-ridden country
حسب: Wesam S. Ahmed (10170053)
منشور في: (2024)

Influenza prevalence and vaccine efficacy among diabetic patients in Qatar
حسب: Swapna Thomas (17337925)
منشور في: (2023)

Influenza prevalence and vaccine efficacy among diabetic patients in Qatar
حسب: Swapna, Thomas
منشور في: (2023)

Motivators and barriers of seasonal influenza vaccination among primary health care physicians in Qatar
حسب: Kamran Aziz (21633128)
منشور في: (2024)

BNT162b2 Versus mRNA‐1273 Vaccines: Comparative Analysis of Long‐Term Protection Against SARS‐CoV‐2 Infection and Severe COVID‐19 in Qatar
حسب: Hiam Chemaitelly (439114)
منشور في: (2024)

Antibody‐dependent enhancement (ADE) of SARS‐CoV‐2 in patients exposed to MERS‐CoV and SARS‐CoV‐2 antigens
حسب: Swapna Thomas (17337925)
منشور في: (2024)

SARS‐CoV‐2 infection and effects of age, sex, comorbidity, and vaccination among older individuals: A national cohort study
حسب: Mai A. Mahmoud (9620657)
منشور في: (2023)

Seroprevalence and factors associated with SARS-CoV-2 infection among healthcare workers: cross-sectional study
حسب: Watheq Thabet Taher (17541210)
منشور في: (2023)

Burden and disease pathogenesis of influenza and other respiratory viruses in diabetic patients
حسب: Swapna Thomas (17337925)
منشور في: (2022)

Computational and Transcriptome Analyses Revealed Preferential Induction of Chemotaxis and Lipid Synthesis by SARS-CoV-2
حسب: Hibah Shaath (5599658)
منشور في: (2020)

Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines
حسب: Queenie Fernandes (14557388)
منشور في: (2022)

Qatar Healthcare Workers' COVID-19 Vaccine Hesitancy and Attitudes: A National Cross-Sectional Survey
حسب: Rajeev Kumar (195329)
منشور في: (2021)

T‐cell responses and therapies against SARS‐CoV‐2 infection
حسب: Salman M. Toor (8854751)
منشور في: (2023)

Addressing bias in the definition of SARS-CoV-2 reinfection: implications for underestimation
حسب: Hiam Chemaitelly (439114)
منشور في: (2024)

Follow‐Up and Comparative Assessment of SARS‐CoV‐2 IgA, IgG, Neutralizing, and Total Antibody Responses After BNT162b2 or mRNA‐1273 Heterologous Booster Vaccination
حسب: Salma Younes (6424865)
منشور في: (2024)

Molecular screening of phytocompounds targeting the interface between influenza A NS1 and TRIM25 to enhance host immune responses
حسب: Muhammad, Suleman
منشور في: (2024)

Mapping routine measles vaccination in low- and middle-income countries
حسب: Local Burden of Disease Vaccine Coverage Collaborators (11548903)
منشور في: (2020)

Kikuchi-Fujimoto disease following SARS CoV2 vaccination: Case report
حسب: Hussam Al Soub (17269024)
منشور في: (2021)

Will Host Genetics Affect the Response to SARS-CoV-2 Vaccines? Historical Precedents
حسب: Maria K. Smatti (4675852)
منشور في: (2022)

Effects of previous infection, vaccination, and hybrid immunity against symptomatic Alpha, Beta, and Delta SARS-CoV-2 infections: an observational study
حسب: Heba N. Altarawneh (19482436)
منشور في: (2023)

Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: an observational study
حسب: Suelen H. Qassim (13777594)
منشور في: (2023)

Evaluation of mortality attributable to SARS-CoV-2 vaccine administration using national level data from Qatar
حسب: Adeel A. Butt (3697705)
منشور في: (2023)

Comparative analysis of within-host diversity among vaccinated COVID-19 patients infected with different SARS-CoV-2 variants
حسب: Hebah A., Al-Khatib
منشور في: (2022)

Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1
حسب: Natalie C Galles (9715361)
منشور في: (2021)

SARS‐CoV‐2 infection triggers more potent antibody‐dependent cellular cytotoxicity (ADCC) responses than mRNA‐, vector‐, and inactivated virus‐based COVID‐19 vaccines
حسب: Hadeel T. Zedan (12535521)
منشور في: (2024)

Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: a national cohort study
حسب: Hiam Chemaitelly (439114)
منشور في: (2023)

Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: an observational study
حسب: Suelen H., Qassim
منشور في: (2023)

Malaria vaccination in Africa: A mini-review of challenges and opportunities
حسب: David B. Olawade (19325911)
منشور في: (2024)

Long COVID treated successfully with antivirals in a rituximab-treated follicular lymphoma patient with persistent negative-antibodies to SARS-CoV2
حسب: Elias Tayar (16488567)
منشور في: (2023)

Neutralizing antibodies against SARS-CoV-2 are higher but decline faster in mRNA vaccinees compared to individuals with natural infection
حسب: Haissam Abou-Saleh (497840)
منشور في: (2022)

Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 10–13 September 2024
حسب: Lambach, Philipp
منشور في: (2025)

Will influenza A(H3N8) cause a major public health threat?
حسب: Hadi M., Yassine
منشور في: (2022)

<i>In silico </i>formulation of a next-generation multiepitope vaccine for use as a prophylactic candidate against Crimean-Congo hemorrhagic fever
حسب: Rahat Alam (9286527)
منشور في: (2023)

Hyponatremia and SARS-CoV-2 infection: A narrative review
حسب: Elmukhtar Habas (14777677)
منشور في: (2022)

Development and validation of a multi-dimensional COVID-19 vaccine hesitancy questionnaire
حسب: Hamed Hammoud (9639309)
منشور في: (2023)

Qatar COVID-19 vaccination story: what are the success drivers?
حسب: Khalid Elmardi (17868190)
منشور في: (2024)

Cannot write session to /tmp/vufind_sessions/sess_j7v461gvkgvl4qfks9g9lsdevg